Does SummaCare Cover Viagra?

What SummaCare Is and Why Plan Type Matters

SummaCare is a regional managed-care organization headquartered in Akron, Ohio, operating Medicare Advantage, commercial employer-sponsored, and individual-market plans across northeastern Ohio. The coverage rules for Viagra or sildenafil depend almost entirely on which SummaCare product you hold.

Commercial vs. Medicare Advantage Plans

Commercial employer-sponsored plans negotiate their own formularies. An employer can elect to include or exclude ED medications entirely, independent of SummaCare's default drug list. Medicare Advantage plans, by contrast, follow federal rules. Section 1860D-2(e)(2)(A) of the Social Security Act explicitly excludes drugs used for erectile dysfunction from standard Medicare Part D coverage unless a separate rider is added. Medicare Advantage plans that include an enhanced drug benefit may add a Part D "gap" tier covering sildenafil at higher cost-sharing.

Individual and Marketplace Plans

ACA marketplace plans sold through SummaCare are not required by federal law to cover ED medications. The Essential Health Benefits benchmark does not list erectile dysfunction drugs as a mandated category. Ohio does not have a state mandate requiring commercial insurers to cover Viagra or sildenafil, so coverage is purely at the plan's discretion.

The "Lifestyle Drug" Exclusion

Many commercial plans carry a blanket exclusion for "lifestyle" or "convenience" drugs. Viagra appeared on these lists when it launched in 1998, and the classification has persisted in many formularies even though erectile dysfunction is a recognized medical condition linked to cardiovascular disease, diabetes, and hypogonadism. The American Urological Association's 2018 guideline on erectile dysfunction states that ED affects approximately 30 million men in the United States and is associated with substantial comorbidity burden. That medical context can support a prior authorization argument.

How to Check Your SummaCare Formulary Right Now

Step 1: Locate the Formulary Document

Every SummaCare plan must publish an Annual Notice of Change and a current drug formulary. Log in to your member portal at summacare.com, manage to "Prescription Drug Coverage," and download the PDF formulary for your plan year. Search for "sildenafil" and "Viagra" separately, because some formularies list only the generic.

Step 2: Identify the Tier

If sildenafil appears, note the tier number. Tier 1 and Tier 2 drugs typically carry $10, $50 copays. Tier 3 "preferred brand" drugs may cost $60, $120 per fill. Tier 4 or specialty tiers can require coinsurance of 30 to 50%, making brand-name Viagra effectively out-of-pocket for most members.

Step 3: Check for a Quantity Limit

Even plans that cover sildenafil often cap dispensing at six to eight tablets per 30-day supply. This quantity limit is standard across commercial insurers and reflects the classification of the drug as used episodically rather than daily.

Step 4: Call Member Services

Call the number on the back of your SummaCare ID card before your physician submits a prescription. Ask the representative: (1) Is sildenafil or Viagra on my formulary? (2) Does it require prior authorization? (3) Is there a quantity limit? Document the representative's name, date, and time of the call.

Prior Authorization for Sildenafil: What Your Doctor Must Submit

Prior authorization (PA) is a written request from your prescribing physician to SummaCare explaining why the medication is medically necessary. For sildenafil, PA letters typically must document:

• A confirmed diagnosis of erectile dysfunction (ICD-10 code N52.9 or a more specific code)
• Duration of symptoms (most plans require at least three months of documented ED)
• Ruling out or treatment of underlying causes such as hypogonadism, diabetes, or vascular disease
• Any contraindications to alternative treatments
• Absence of concurrent nitrate use (an absolute contraindication to PDE-5 inhibitors per FDA labeling)

The FDA's prescribing information for Viagra identifies concurrent organic nitrate therapy as an absolute contraindication because the combination can cause severe, potentially fatal hypotension. Your physician's PA letter should explicitly state that nitrates are not being used.

What Happens After Submission

SummaCare is required under Ohio insurance law to respond to urgent PA requests within 72 hours and routine requests within 14 calendar days. If the PA is denied, you receive a written Explanation of Benefits (EOB) stating the reason.

Appealing a Denial: Your Rights and Real Success Rates

A denial is not the end. Federal and Ohio state law give you the right to an internal appeal followed by an external independent review.

Internal Appeal

File within 60 days of the denial notice. Your physician should submit a peer-reviewed letter citing the medical comorbidities driving the ED diagnosis. A 2021 KFF analysis of ACA marketplace plans found that insurers overturned approximately 39 to 59% of claim denials when members filed formal appeals. Most members never appeal, which means billions in denied claims go unchallenged each year.

External Review

If the internal appeal fails, request an Independent Medical Review (IMR) through the Ohio Department of Insurance. An independent reviewer, not employed by SummaCare, evaluates whether the denial was medically appropriate. External reviews reverse insurer decisions in a meaningful minority of cases, particularly when a physician letter documents cardiovascular or psychological harm from untreated ED.

Key Appeal Language

When your physician writes the appeal, the phrase to include is that erectile dysfunction "impairs activities of daily living and is associated with significant psychological morbidity." A study in the Journal of Sexual Medicine (N=6,291) found that men with ED had significantly higher rates of depression and relationship distress compared with age-matched controls, supporting the argument that treatment is medically necessary rather than elective.

Generic Sildenafil: The Most Practical Path to Coverage

Brand-name Viagra and generic sildenafil contain the same active molecule at the same doses (25 mg, 50 mg, 100 mg). The FDA's Office of Generic Drugs confirms that approved generic drugs must demonstrate bioequivalence to the reference listed drug, meaning the same rate and extent of absorption within accepted statistical limits.

Why Generic Sildenafil Changes the Equation

Generic sildenafil entered the U.S. Market in December 2017 after Pfizer's composition-of-matter patent expired. Retail cash prices dropped from roughly $65 per tablet for Viagra to under $8 per tablet for generic sildenafil at major chains, and under $1 per tablet at GoodRx-contracted pharmacies for a 90-day supply. Even if SummaCare denies coverage, the out-of-pocket cost for generic sildenafil is often lower than the copay for a covered brand-name drug.

Efficacy Data for Sildenafil

A Cochrane systematic review (2021) of PDE-5 inhibitors for erectile dysfunction covering 82 randomized controlled trials and more than 21,000 men found that sildenafil significantly improved erectile function scores compared with placebo (mean difference on the International Index of Erectile Function approximately 6.6 points). Response rates in the 60 to 70% range are consistent across dosing studies.

Dosing Overview

Sildenafil is typically prescribed at 50 mg taken 30 to 60 minutes before sexual activity. The dose may be adjusted to 25 mg based on tolerability or to 100 mg for inadequate response. Per FDA labeling, the maximum recommended dosing frequency is once per day. Daily low-dose sildenafil (25 mg daily) is sometimes used off-label for men who benefit from more spontaneous timing, though this regimen is not FDA-approved specifically for ED.

Alternatives That SummaCare May Cover Instead

If sildenafil is excluded, ask your physician about these alternatives. Some SummaCare formularies cover at least one PDE-5 inhibitor even when excluding others.

Tadalafil (Cialis Generic)

Generic tadalafil has been available since 2018. The daily 5 mg dose is FDA-approved for both erectile dysfunction and benign prostatic hyperplasia (BPH). If you carry a dual diagnosis of ED and BPH, tadalafil 5 mg may be covered under the BPH indication even when ED drugs are excluded, because BPH treatment is not classified as a lifestyle drug. A randomized trial (N=695) in the Journal of Urology demonstrated that tadalafil 5 mg once daily significantly improved both International Prostate Symptom Score and erectile function vs. Placebo at 12 weeks.

Vardenafil (Levitra Generic)

Generic vardenafil is available but less widely stocked. Its pharmacokinetic profile is similar to sildenafil. Some formularies that exclude sildenafil include vardenafil, or vice versa, simply due to contracting history.

Avanafil (Stendra)

Avanafil remains brand-only as of early 2025. It has a faster onset (15 minutes in some men) and may be preferred for patients who experience delayed absorption with sildenafil. It is rarely covered without PA and a documented trial-and-failure of generic PDE-5 inhibitors.

Testosterone Replacement Therapy When Hypogonadism Is Present

Erectile dysfunction in the setting of documented hypogonadism (total testosterone below 300 ng/dL on two morning fasting samples, per Endocrine Society 2018 Clinical Practice Guidelines) may respond to testosterone replacement alone or in combination with a PDE-5 inhibitor. Testosterone replacement therapy (TRT) is covered by most commercial plans when hypogonadism is confirmed, and treating the underlying hormonal cause may resolve ED without requiring a separate PDE-5 inhibitor claim.

The HealthRX clinical team uses a structured three-step evaluation for men presenting with ED and potential insurance coverage barriers: (1) test total and free testosterone to rule out hypogonadism before initiating PDE-5 inhibitors, since TRT is more reliably covered; (2) confirm absence of nitrate use and cardiovascular contraindications per the Princeton Consensus III criteria; (3) submit a PA for generic sildenafil first, citing the lowest-cost formulary alternative, before escalating to brand or specialty agents. This sequence typically resolves coverage in fewer than three weeks for men with uncomplicated ED.

Cardiovascular Considerations: Who Should Not Take Sildenafil

Not every man is a candidate for sildenafil regardless of cost or coverage. The Princeton Consensus Panel III (published in Mayo Clinic Proceedings, 2012) classifies men with ED into low-, intermediate-, and high-cardiovascular-risk categories.

High-Risk Contraindications

Men with any of the following should not take sildenafil without cardiology clearance:

• Unstable or refractory angina
• Uncontrolled hypertension (systolic above 170 mmHg)
• Recent myocardial infarction or stroke within the prior six weeks
• High-risk arrhythmias
• Hypertrophic obstructive cardiomyopathy with significant obstruction

The co-administration of sildenafil with any organic nitrate (nitroglycerin, isosorbide mononitrate, isosorbide dinitrate) is absolutely contraindicated. The combination produces additive nitric oxide pathway activation, which can drop systolic blood pressure by 50 mmHg or more.

Side Effect Profile

Common adverse effects reported in key trials included headache (16%), flushing (10%), dyspepsia (7%), and visual disturbances described as a blue-green color tinge (3%). Per FDA prescribing information, these effects are dose-dependent and usually transient.

The Role of Telehealth in Getting Sildenafil Prescribed

Telehealth platforms, including HealthRX, allow board-certified physicians to evaluate erectile dysfunction, review medical history for contraindications, and prescribe sildenafil or generic alternatives without an in-person visit. Every state in the U.S. Permits telehealth prescribing for ED medications as of 2024, provided the physician completes an adequate clinical evaluation.

What a Telehealth ED Visit Includes

A thorough telehealth ED evaluation should include:

• Review of cardiovascular history and current medications (especially nitrates)
• Blood pressure documentation (self-reported or pharmacy-measured within 30 days)
• Symptom duration and severity using a validated instrument such as the International Index of Erectile Function (IIEF-5), a five-question scale with scores ranging from 5 (severe ED) to 25 (no ED)
• Discussion of lifestyle factors: obesity (BMI above 30 is associated with a 30% higher ED prevalence per NHANES data), smoking, alcohol use, and sedentary activity
• Optional testosterone screening if symptoms or history suggest hypogonadism

Using Insurance for Telehealth Prescriptions

A prescription for generic sildenafil written by a telehealth physician can be submitted to any pharmacy that accepts your SummaCare coverage. The prescription itself does not indicate it was generated via telehealth, so formulary rules apply identically. If SummaCare covers generic sildenafil on your plan, the telehealth-issued prescription qualifies for the same copay as one written in a traditional office visit.

Cost Comparison: Insurance vs. Cash-Pay Options

Even without SummaCare coverage, generic sildenafil may cost less than your specialty-tier copay.

| Option | Typical Cost Per Tablet | Notes | |---|---|---| | Brand Viagra, no insurance | $65, $100 | Pfizer patient assistance available | | Generic sildenafil, no insurance, retail | $4, $8 | Walgreens, CVS, Rite Aid | | Generic sildenafil, GoodRx coupon | $0.90, $3 | 90-count supply at contracted pharmacies | | Generic sildenafil, SummaCare Tier 1 | $5, $15 copay | If on formulary | | Generic sildenafil, SummaCare Tier 3 | $40, $90 copay | Brand-preferred tier | | Tadalafil 5 mg daily, GoodRx coupon | $0.60, $2 per tablet | Often cheaper than sildenafil per-day if using daily |

GoodRx pricing data as of 2024 suggests that cash-pay prices for a 30-tablet supply of 50 mg sildenafil at major chain pharmacies average $28, which is below the Tier 3 copay on many commercial plans.

What HealthRX Physicians Say About Coverage Denials

"When a patient is denied coverage for sildenafil, the first thing I do is check whether they have an underlying diagnosis of hypogonadism or diabetes. Both conditions make the medical necessity argument far stronger, and many payers respond differently once the comorbidity is documented properly in the PA letter."

The Endocrine Society's 2021 position on male sexual health notes that testosterone deficiency directly impairs both libido and the nitric oxide signaling pathway that sildenafil depends on, meaning that untreated hypogonadism can reduce the drug's effectiveness even when coverage is obtained.

A 2019 survey published in Translational Andrology and Urology (N=312 urologists) found that 68% of responding urologists reported that insurance prior authorization requirements delayed treatment initiation for ED by two or more weeks, and 22% reported that patients abandoned treatment entirely due to cost and administrative burden.

Step-by-Step Action Plan for SummaCare Members

1. Download your current SummaCare formulary from the member portal and search for "sildenafil."
2. Call member services (number on your ID card) to confirm PA requirements and quantity limits.
3. Schedule a visit (telehealth or in-person) with a physician who will document your ED diagnosis with an ICD-10 code and check testosterone levels.
4. Ask your physician to submit a PA for generic sildenafil 50 mg, citing duration of symptoms, any cardiovascular or metabolic comorbidities, and the absence of nitrate use.
5. If denied, file an internal appeal within 60 days. Ask your physician to write a peer-reviewed letter citing the psychological and cardiovascular comorbidity burden of untreated ED.
6. While the appeal is pending, price generic sildenafil at your pharmacy with a GoodRx coupon. The out-of-pocket cost may be lower than your copay even if coverage is ultimately approved.
7. If the internal appeal fails, file for external independent review through the Ohio Department of Insurance within the deadline stated in your denial letter.

A 30-day supply of generic sildenafil 50 mg at a GoodRx-contracted pharmacy costs approximately $28 cash-pay as of January 2025, which is the most reliable fallback if SummaCare denies coverage entirely.